Safety and Tolerability of Frovatriptan to Prevention of Menstrually Associated Migraine (MAM) Headaches

NCT01035983 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

550

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: Frovatriptan 2.5 mg

Sponsor

Endo Pharmaceuticals

Collaborators

[object Object]